期刊文献+

青蒿素及其衍生物对肿瘤干细胞的作用研究进展

Research Progress on the Effect of Artemisinin and Its Derivatives on Cancer Stem Cells
下载PDF
导出
摘要 肿瘤干细胞是一类具有干细胞样特性的细胞,具有独特的自我更新、增殖和分化能力,在肿瘤的发生、转移和复发中起着至关重要的作用,发现肿瘤干细胞抑制剂或者抑制肿瘤干细胞活性可能为肿瘤治疗提供新的策略。青蒿素是从菊科植物黄花蒿中提取分离的含有过氧桥药效团的倍半萜内酯化合物,是著名的抗疟药物。近年来的研究表明,青蒿素及其衍生物可以抗肿瘤,且具有选择性高、高效低毒、无交叉耐药的特点,其抗肿瘤不仅表现在抑制肿瘤细胞的活性上,而且也可抑制肿瘤干细胞的活性。因此,就青蒿素及其衍生物对肿瘤干细胞的影响及相关作用机制的研究进展进行综述。 Cancer stem cells(CSCs)are a kind of cells with stem-like properties,which have unique abilities of self-renewal,proliferation and differentiation.They play a vital role in the occurrence,metastasis and recurrence of the tumor.Therefore,the discovery of inhibitors against CSCs or the inhibition of the activity of CSCs may provide a new treatment strategy for tumor.Artemisinin,a famous antimalarial drug containing a peroxide bridge pharmacophore,is a sesquiterpene lactone compound extracted from compositae plant Artemisia annua.In recent years,studies have shown that artemisinin and its derivatives have the antitumor activity with high selectivity,high efficiency and low toxicity,and without cross resistance.They have the antitumor activity not only in inhibiting the activity of tumor cells,but also on CSCs.Therefore,this paper reviews the influence and relevant mechanisms of action of artemisinin and its derivatives on CSCs.
作者 许藏藏 肖林凡 温顺 牟玲丽 Xu Cangcang;Xiao Linfan;Wen Shun;Mu Lingli(Key Lab. of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University School of Medicine, Changsha 410013, China)
出处 《中国野生植物资源》 CSCD 2020年第8期50-53,共4页 Chinese Wild Plant Resources
基金 湖南省教育厅一般项目(17C0973) 大学生创新训练计划项目(201900110)。
关键词 青蒿素 衍生物 肿瘤干细胞 作用机制 Artemisinin Derivative CSCs Mechanism of action
  • 相关文献

参考文献3

二级参考文献81

  • 1Hess KR, Broglio KR, Bondy ML. Adult glioma incidence trends in the United States, 1977-2000. Cancer. 2004; 101 (10):2293-2299.
  • 2Rosenfeld MR, Pruitt AA. Management of malignant gliomas and primary CNS lymphoma: standard of care and future directions. Continuum (Minneap Minn). 2012;18(2):406-415.
  • 3Bexell D, Svensson A, Bengzon J. Stem cell-based therapy for malignant glioma. Cancer Treat Rev. 2013; 39(4):358-365.
  • 4Cheng L, Wu Q, Guryanova OA, et al. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun. 2011 ;406(4):643-648.
  • 5Khoshnevisan A. An overview of therapeutic approaches to brain tumor stem cells. Med J Islam Repub Iran. 2012;26(1):31-40.
  • 6Stupp R, Mason WP, van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 352(10):987-996.
  • 7Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010 60(3): 166-193.
  • 8Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432 (7015):396-401.
  • 9Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63(18):5821-5828.
  • 10Mao H, Gu H, Qu X, et al. Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro. Int J Mol Med. 2013;31(1):213-218.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部